On side

By Douglas Peddicord, PhD, Executive Director of the Association of Clinical Research Organizations (ACRO).

ACRO is very supportive of the Critical Path initiative and is moving actively to join the FDA and other stakeholders to identify barriers that exist along the current development pathway and propose solutions to diminish unnecessary delays in the testing and introduction of new medical products.